Epigenetic variation and human disease

Journal of Nutrition

Volumn 132, Issue 8 SUPPL., 2002, Pages

  Issa, Jean Pierre ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Aging; CpG island methylator phenotype; CpG islands; DNA methylation; Epigenetics

Indexed keywords

AGING; CONFERENCE PAPER; CPG ISLAND; DISEASE SEVERITY; DNA METHYLATION; ENVIRONMENTAL FACTOR; GENE SILENCING; GENETIC VARIABILITY; HEREDITY; HUMAN; LIFESTYLE; LIVER CIRRHOSIS; MEIOSIS; NEOPLASM; ULCERATIVE COLITIS;

EID: 0036324919     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.8.2388s     Document Type: Conference Paper

References (65)

1. Epigenetics: Regulation through repression
2. The role of DNA methylation in mammalian epigenetics
3. RNA interference: Listening to the sound of silence
4. Translating the histone code
5. Methylation-induced repression - Belts, braces, and chromatin
6. Alterations in DNA methylation - A fundamental aspect of neoplasia
7. Cancer epigenetics comes of age
8. DNA methylation in early development
9. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
10. Aging, DNA methylation, and cancer
11. CpG islands
12. Aging and DNA methylation in colorectal mucosa and cancer
13. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells
14. CpG island methylator phenotype in colorectal cancer
15. Temporal and spatial patterns of transgene expression in aging adult mice provide insights about the origins, organization, and differentiation of the intestinal epithelium
16. Transgene silencing by the host genome defense: Implications for the evolution of epigenetic control mechanisms in plants and vertebrates
17. Investigating stem cells in human colon by using methylation patterns
18. CpG island methylator phenotypes in aging and cancer
19. CpG island methylation in colorectal adenomas
20. Accelerated age-related CpG island methylation in ulcerative colitis
21. CpG-island methylation in aging and cancer
22. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
23. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors
24. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors
25. The role of cyclooxygenases in inflammation, cancer, and development
26. Association between CpG island methylation and microsatellite instability in colorectal cancer
27. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
28. Genetic instabilities in human cancers
29. The establishment and maintenance of DNA methylation patterns in mouse somatic cells
30. Serrated route to colorectal cancer: Back street or super highway?
31. Concordant island methylation in hyperplastic polyposis
32. The epigenetics of colorectal cancer
33. Lessons from hereditary colorectal cancer
34. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
35. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
36. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer
37. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
38. Methylation profiling in acute myeloid leukemia
39. Hypermethylation of multiple genes in pancreatic adenocarcinoma
40. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes
41. Stabilization of DNA (cytosine-5)-methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts
42. Switch from mono-allelic to bi-allelic human IGF2 promoter methylation during aging and carcinogenesis
43. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system
44. Pathophysiological insights from studies of retrieved coronary atherectomy tissue
45. Methylation of the estrogen receptor-α gene promoter is selectively increased in proliferating human aortic smooth muscle cells
46. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
47. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
48. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure
49. Understanding the molecular basis of fragile X syndrome
50. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia
51. Methylation of the ABL1 promoter in chronic myelogenous leukemia: Lack of prognostic significance
52. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene
53. The inheritance of epigenetic defects
54. 5-Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinogens which result
55. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet
56. Epigenetic mechanisms of drug resistance: Drug-induced DNA hypermethylation and drug resistance
57. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
58. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer
59. The insertion of foreign DNA into mammalian genomes and its consequences: A concept in oncogenesis
60. Infection with human immunodeficiency virus type 1 upregulates DNA (cytosine5)-methyltransferase, resulting in de novo methylation of the γ interferon (IFN-γ) promoter and subsequent downregulation of IFN-γ production
61. Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus
62. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes
63. DNA methylation and environmental exposures in human hepatocellular carcinoma
64. Altering gene expression with 5-azacytidine
65. Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications